Hosted on MSN1mon
Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker saysIn a new head-to-head trial, drugmaker Eli Lilly said Wednesday that patients using its obesity medication Zepbound lost significantly more weight than those who were given competitor Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback